Clinical significance of SPARC gene expression in patients with gastric cancer (Q43940466)

28 November 2017

title

Clinical significance of SPARC gene expression in patients with gastric cancer (English)

1 reference

28 November 2017

Tsutomu Sato

1 reference

28 November 2017

Takashi Oshima

1 reference

28 November 2017

Naoto Yamamoto

1 reference

28 November 2017

Takanobu Yamada

1 reference

28 November 2017

Shinichi Hasegawa

1 reference

28 November 2017

Norio Yukawa

1 reference

28 November 2017

Kazushi Numata

1 reference

28 November 2017

Chikara Kunisaki

1 reference

28 November 2017

Katsuaki Tanaka

1 reference

28 November 2017

Manabu Shiozawa

1 reference

28 November 2017

Takaki Yoshikawa

1 reference

28 November 2017

Makoto Akaike

1 reference

28 November 2017

Yasushi Rino

1 reference

28 November 2017

Toshio Imada

1 reference

28 November 2017

Munetaka Masuda

1 reference

28 November 2017

publication date

9 September 2013

1 reference

Journal of Surgical Oncology

28 November 2017

published in

1 reference

28 November 2017

volume

108

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

364-368

1 reference

28 November 2017

cites work

Global cancer statistics

1 reference

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

21 January 2018

1 reference

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

Anti-cancer role of SPARC, an inhibitor of adipogenesis

21 January 2018

1 reference

SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury

21 January 2018

1 reference

Matricellular proteins: extracellular modulators of cell function

21 January 2018

1 reference

SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma

21 January 2018

1 reference

SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.

21 January 2018

1 reference

Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers

21 January 2018

1 reference

Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer

21 January 2018

1 reference

SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer

21 January 2018

1 reference

Differential Expression of SPARC in Intestinal-type Gastric Cancer Correlates with Tumor Progression and Nodal Spread

21 January 2018

1 reference

The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

21 January 2018

1 reference

SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas

21 January 2018

1 reference

SPARC is associated with gastric cancer progression and poor survival of patients

21 January 2018

1 reference

The role of SPARC protein expression in the progress of gastric cancer

21 January 2018

1 reference

Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance

21 January 2018

1 reference

Gene expression analysis identifies over-expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer

21 January 2018

1 reference

Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases

21 January 2018

1 reference

Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes

21 January 2018

1 reference

Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels

21 January 2018

1 reference

Osteonectin downregulates E-cadherin, induces osteopontin and focal adhesion kinase activity stimulating an invasive melanoma phenotype.

21 January 2018

1 reference

SPARC, FOXP3, CD8 and CD45 Correlation with Disease Recurrence and Long-Term Disease-Free Survival in Colorectal Cancer

21 January 2018

1 reference

Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer

21 January 2018

1 reference

The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.

21 January 2018

1 reference

Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival

21 January 2018

1 reference

SPARC is a source of copper-binding peptides that stimulate angiogenesis

21 January 2018

1 reference

Modulation of matrix remodeling by SPARC in neoplastic progression

21 January 2018

1 reference

SPARC in cancer biology: its role in cancer progression and potential for therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23425

1 reference

28 November 2017

1 reference